HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

V-ATPase blockade reduces renal gluconeogenesis and improves insulin secretion in type 2 diabetic rats.

Abstract
Vacuolar H+-adenosine triphosphatase (V-ATPase) stimulates vesicular acidification that may activate cytoplasmic enzymes, hormone secretion and membrane recycling of transporters. We investigated the effect of blockade of V-ATPase by bafilomycin B1 on renal gluconeogenesis, mitochondrial enzymes, and insulin secretion in type 2 diabetic rats. Spontaneous type 2 diabetic Torii rats were treated with intraperitoneal injection of bafilomycin B1 for 1 week, and the kidneys were examined after 24 h of starvation in metabolic cages. The renal expression and activity of V-ATPase were increased in the brush border membrane of the proximal tubules in diabetic rats. The blockade of V-ATPase by bafilomycin B1 reduced renal V-ATPase activity and urinary ammonium in diabetic rats. Treatment with bafilomycin suppressed the enhanced renal gluconeogenesis enzymes and mitochondrial electron transport enzymes in type 2 diabetic rats and reduced the renal cytoplasmic glucose levels. The insulin index and pancreatic insulin granules were decreased in diabetic rats with increased V-ATPase expression in islet cells, and treatment with bafilomycin B1 reversed these changes and increased the insulin secretion index. Hepatosteatosis in type 2 diabetic rats was ameliorated by bafilomycin treatment. As a consequence, treatment with bafilomycin B1 significantly decreased the plasma glucose level after 24 h of starvation in diabetic rats. In conclusion, a V-ATPase inhibitor improved plasma glucose levels in type 2 diabetes by inhibiting renal mitochondrial gluconeogenesis and improving insulin secretion.
AuthorsJun Hirao, Akihiro Tojo, Saaya Hatakeyama, Hiroshi Satonaka, Toshihiko Ishimitsu
JournalHypertension research : official journal of the Japanese Society of Hypertension (Hypertens Res) Vol. 43 Issue 10 Pg. 1079-1088 (10 2020) ISSN: 1348-4214 [Electronic] England
PMID32382157 (Publication Type: Journal Article)
Chemical References
  • Blood Glucose
  • Macrolides
  • bafilomycin B1
  • Vacuolar Proton-Translocating ATPases
Topics
  • Animals
  • Blood Glucose (drug effects)
  • Diabetes Mellitus, Experimental (drug therapy)
  • Diabetes Mellitus, Type 2 (drug therapy)
  • Drug Evaluation, Preclinical
  • Gluconeogenesis (drug effects)
  • Insulin Resistance
  • Insulin Secretion (drug effects)
  • Kidney (drug effects, enzymology)
  • Lipid Metabolism (drug effects)
  • Liver (drug effects)
  • Macrolides (pharmacology, therapeutic use)
  • Male
  • Pancreas (drug effects)
  • Rats
  • Vacuolar Proton-Translocating ATPases (antagonists & inhibitors, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: